U.S. Markets closed

RTI Surgical receives CE Mark approval for Fortiva Porcine Dermis

RTI Surgical that the company received approval to CE mark Fortiva Porcine Dermis and will begin distribution throughout Europe. Fortiva received 510(k) clearance from the FDA in March 2013 and was launched in the U.S. in July 2013. The implant is manufactured at RTI’s Neunkirchen, Germany facility.